Fat burning peptides: an evidence-based ranking

Not all fat burning peptides work the same way. Understanding the mechanism helps you choose the right one. Direct lipolysis — peptides that tell your fat cells to release stored fat and burn it for energy. AOD-9604 is the primary example. It activates beta-3 adrenergic receptors on fat cells, triggering the release of fatty acids without affecting muscle tissue, blood sugar, or appetite. This is true “fat burning” in the literal sense. Appetite suppression — GLP-1 agonists (semaglutide, tirzepatide) reduce caloric intake by making you feel full. You lose weight because you eat less. Highly effective but the weight loss includes both fat AND muscle. Up to 40% of weight lost on semaglutide can be lean mass. Metabolic optimization — growth hormone secretagogues (CJC-1295, Ipamorelin) and mitochondrial peptides (MOTS-c) increase your basal metabolic rate, improve insulin sensitivity, and shift your body’s energy partitioning toward burning fat and preserving muscle. Slower-acting but more sustainable for long-term body composition.

Semaglutide (oral) — The most clinically validated fat loss compound in history. FDA-approved. Phase 3 trials with tens of thousands of participants. 15–20% average body weight reduction. Available now through telehealth as an oral tablet (no injection needed). The gold standard, but comes with appetite suppression side effects and potential muscle loss. From $179/month compounded. Tirzepatide (oral) — Dual GLP-1/GIP agonist showing even stronger weight loss than semaglutide in head-to-head trials. SURMOUNT data showed up to 22.5% body weight reduction. Oral formulation available through compounding. From $279/month. AOD-9604 (oral capsule) — The targeted fat burner. Phase 2 trial data in 300+ participants. Fat loss without appetite suppression, muscle wasting, or metabolic disruption. Oral capsule form available. The preferred option for body recomposition. Pending FDA Category 1 reclassification. Expected $150–300/month.

Tesamorelin — Actually FDA-approved, but only for HIV-associated lipodystrophy (visceral belly fat). Stimulates growth hormone release, specifically reducing abdominal fat. Used off-label for body composition. Strong evidence for visceral fat reduction. Injectable only. $200–400/month. CJC-1295 / Ipamorelin stack — Boosts natural GH production, which increases metabolic rate and promotes fat-to-muscle shift over time. Not a rapid fat burner but excellent for long-term recomposition alongside exercise. Injectable. Pending reclassification. $200–450/month. Sermorelin — A growth hormone releasing hormone analog. Similar mechanism to CJC-1295 but shorter half-life. FDA-approved for GH deficiency in children, used off-label for adult optimization. Injectable. $150–300/month.

MOTS-c — Mitochondrial peptide that mimics exercise at the cellular level. Activates AMPK, improves insulin sensitivity. Lifespan extension demonstrated in mice. Fascinating mechanism but human clinical data is minimal. Injectable only. Pending reclassification. 5-Amino-1MQ — A small molecule (not technically a peptide) that inhibits NNMT, an enzyme associated with fat storage. Preclinical data shows enhanced fat cell metabolism. Very early stage. Available through some compounding pharmacies.

Melanotan II — Sometimes marketed for fat loss alongside its primary use for tanning. Associated with cardiovascular side effects, nausea, and potential melanoma risk. Expected to remain on the FDA Category 2 restricted list. Avoid. GHRP-6 — A growth hormone secretagogue that causes extreme hunger as a side effect. Counterproductive for fat loss. Also has cortisol and prolactin elevation issues. Expected to remain restricted. DNP (2,4-dinitrophenol) — Not a peptide. An industrial chemical sometimes sold as a fat burner in underground markets. Has killed people. Never use this. Any “research chemical” vendor selling pre-mixed fat loss peptide blends — these products have no quality control, no physician oversight, and frequently contain different compounds than labeled. Independent testing has documented contamination and mislabeling across the gray market.

For maximum fat loss with body composition preservation, the protocol gaining the most traction in clinical practice is: Primary: AOD-9604 (oral) for direct fat metabolism — targets fat cells specifically without affecting muscle, appetite, or blood sugar. Support: CJC-1295/Ipamorelin (injectable) for GH optimization — increases basal metabolic rate, improves sleep, and enhances recovery from exercise. Alternative primary: Oral semaglutide if significant weight loss is the priority and muscle preservation is secondary. Complement: MOTS-c for metabolic resilience if you’re in the longevity-optimization mindset. All peptide stacks should be designed and monitored by a licensed physician who can adjust dosing based on your response, bloodwork, and goals. PeptideMaxxers connects you with providers who specialize in these protocols.

The only safe and legal pathway for prescription fat burning peptides is through a licensed physician and an FDA-registered compounding pharmacy. Oral GLP-1 medications (semaglutide, tirzepatide) are available now through telehealth platforms including PeptideMaxxers. AOD-9604, CJC-1295/Ipamorelin, and MOTS-c are pending FDA reclassification from Category 2 to Category 1. Once reclassified, they will be available through the same physician-supervised telehealth pathway. PeptideMaxxers is building the platform to make this access seamless. Take a 2-minute assessment, get a physician review, and have pharmaceutical-grade peptides shipped to your door. Join the waitlist to be notified the moment fat burning peptides are legally available.